Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-β1-signaling and upregulation of cathepsin B

Biological Chemistry

Volumn 388, Issue 6, 2007, Pages 639-650

  Reisenauer, Anita ^a   Eickelberg, Oliver ^b   Wille, Aline ^c   Heimburg, Anke ^d   Reinhold, Annegret ^c   Sloane, Bonnie F ^e   Welte, Tobias ^f   Bühling, Frank ^c,g  

^a PROBIODRUG AG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d IMTM GmbH   (Germany)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g Inst Clin Chem/Lab Diagnostics   (Germany)

Author keywords

Apoptosis; Cancer; Cysteine; Migration; Promoter; Protease

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CATHEPSIN B; MITOGEN ACTIVATED PROTEIN KINASE; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; BONE MARROW TUMOR; CANCER INVASION; CARCINOGENIC ACTIVITY; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INCUBATION TIME; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; TUMOR RESISTANCE; UPREGULATION;

APOPTOSIS; CATHEPSIN B; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS (GENETICS); RNA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 34249987617     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.072     Document Type: Article

References (54)

1. Barrett, A.J. and Kirschke, H. (1981). Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol. 80, 535-561.
2. Berquin, I.M., Yan, S., Katiyar, K., Huang, L., Sloane, B.F., and Troen, B.R. (1999). Differentiating agents regulate cathepsin B gene expression in HL-60 cells. J. Leukoc. Biol. 66, 609-616.
3. Bisschop, M.M., Revesz, T., Bierings, M., van Weerden, J.F., van Wering, E.R., Hahlen, K., and van der Does-van den Berg, A. (2001). Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia. Leukemia 15, 46-49.
4. Brooks, A.R., Blackhart, B.D., Haubold, K., and Levy-Wilson, B. (1991). Characterization of tissue-specific enhancer elements in the second intron of the human apolipoprotein B gene. J. Biol. Chem. 266, 7848-7859.
5. Chwieralski, C.E., Welte, T., and Buhling, F. (2006). Cathepsin-regulated apoptosis. Apoptosis 11, 143-149.
6. Derynck, R., Akhurst, R.J., and Balmain, A. (2001). TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129.
7. Ebert, W., Knoch, H., Werle, B., Trefz, G., Muley, T., and Spiess, E. (1994). Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res. 14, 895-899.
8. Eickelberg, O., Kohler, E., Reichenberger, F., Bertschin, S., Woodtli, T., Erne, P., Perruchoud, A.P., and Roth, M. (1999). Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3. Am. J. Physiol 276, L814-L824.
9. Felbor, U., Kessler, B., Mothes, W., Goebel, H.H., Ploegh, H.L., Bronson, R.T., and Olsen, B.R. (2002). Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc. Natl. Acad. Sci. USA 99, 7883-7888.
10. Friedrichs, B., Tepel, C., Reinheckel, T., Deussing, J., Von Figura, K., Herzog, V., Peters, C., Saftig, P., and Brix, K. (2003). Thyroid functions of mouse cathepsins B, K, and L. J. Clin. Invest. 111, 1733-1745.
11. Fujise, N., Nanashim, A., Taniguchi, Y., Matsuo, S., Hatano, K., Matsumoto, Y., Tagawa, Y., and Ayabe, H. (2000). Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study. Lung Cancer 27, 19-26.
12. Gerber, A., Wille, A., Welte, T., Ansorge, S., and Bühling, F. (2001). Interleukin-6 and transforming growth factor-β1 control expression of cathepsins B and L in human lung epithelial cells. J. Interferon Cytokine Res. 21, 11-19.
13. Gerber, A., Heimburg, A., Reisenauer, A., Wille, A., Welte, T., and Buhling, F. (2004). Proteasome inhibitors modulate chemokine production in lung epithelial and monocytic cells. Eur. Respir. J. 24, 40-48.
14. Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C., Hanahan, D., and Joyce, J.A. (2006). Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543-556.
15. Gong, Q., Chan, S.J., Bajkowski, A.S., Steiner, D.F., and Frankfater, A. (1993). Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA. DNA Cell Biol. 12, 299-309.
16. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P., and ten Dijke, P. (2002). Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21, 1743-1753.
17. Halangk, W., Lerch, M.M., Brandt-Nedelev, B., Roth,W., Ruthenbuerger, M., Reinheckel, T., Domschke, W., Lippert, H., Peters, C., and Deussing, J. (2000). Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Invest. 106, 773-781.
18. Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J., Shibuya, H., Matsumoto, K., and Nishida, E. (1999). Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression. J. Biol. Chem. 274, 27161-27167.
19. Janowska-Wieczorek, A., Marquez, L.A., Matsuzaki, A., Hashmi, H.R., Larratt, L.M., Boshkov, L.M., Turner, A.R., Zhang, M.C., Edwards, D.R., and Kossakowska, A.E. (1999). Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Br. J. Haematol. 105, 402-411.
20. Jedeszko, C. and Sloane, B.F. (2004). Cysteine cathepsins in human cancer. Biol. Chem. 385, 1017-1027.
21. Keppler, D. and Sloane, B.F. (1996). Cathepsin B: multiple enzyme forms from a single gene and their relation to cancer. Enzyme Protein 49, 94-105.
22. Kobayashi, H., Schmitt, M., Goretzki, L., Chucholowski, N., Calvete, J., Kramer, M., Gunzler, W.A., Janicke, F., and Graeff, H. (1991). Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J. Biol. Chem. 266, 5147-5152.
23. Krepela, E., Prochazka, J., Mynarikova, H., Karova, B., Polak, J., Cermak, J., and Roubkova, H. (1995). Multiple forms of cathepsin B in human lung cancer. Int. J. Cancer 61, 44-53.
24. Krueger, S., Haeckel, C., Buehling, F., and Roessner, A. (1999). Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Cancer Res. 59, 6010-6014.
25. Leivonen, S.K., Chantry, A., Hakkinen, L., Han, J., and Kahari, V.M. (2002). Smad3 mediates transforming growth factor-β-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways. J. Biol. Chem. 277, 46338-46346.
26. Levy, L. and Hill, C.S. (2006). Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 17, 41-58.
27. Li, J.M., Nichols, M.A., Chandrasekharan, S., Xiong, Y., and Wang, X.F. (1995). Transforming growth factor β activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270, 26750-26753.
28. 8+ T cells results in antigen-specific T-cell tolerance. Nat. Med. 6, 1348-1354.
29. Mai, J., Finley, R.L.J., Waisman, D.M., and Sloane, B.F. (2000). Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 275, 12806-12812.
30. Major, M.B. and Jones, D.A. (2004). Identification of a gadd45β 3′ enhancer that mediates SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor β. J. Biol. Chem. 279, 5278-5287.
31. Matsumoto, K., Mizoue, K., Kitamura, K., Tse, W.C., Huber, C.P., and Ishida, T. (1999). Structural basis of inhibition of cysteine proteases by E-64 and its derivatives. Biopolymers 51, 99-107.
32. Mehtani, S., Gong, Q., Panella, J., Subbiah, S., Peffley, D.M., and Frankfater, A. (1999). In vivo expression of an alternatively spliced human tumor message that encodes a truncated form of cathepsin B: subcellular distribution of the truncated enzyme in Cos cells. J. Biol. Chem. 273, 13236-13244.
33. Mohamed, M.M. and Sloane, B.F. (2006). Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6, 764-775.
34. Nagai, A., Terashima, M., Harada, T., Shimode, K., Takeuchi, H., Murakawa, Y., Nagasaki, M., Nakano, A., and Kobayashi, S. (2003). Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis. Clin. Chim. Acta 329, 53-60.
35. Oh, S.P., Seki, T., Goss, K.A., Imamura, T., Yi, Y., Donahoe, P.K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., and Li, E. (2000). Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97, 2626-2631.
36. Piek, E. and Roberts, A.B. (2001). Suppressor and oncogenic roles of transforming growth factor-β and its signaling pathways in tumorigenesis. Adv. Cancer Res. 83, 1-54.
37. Poncelet, A.C. and Schnaper, H.W. (2001). Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2(I) collagen expression in human glomerular mesangial cells. J. Biol. Chem. 276, 6983-6992.
38. Rao, J.S. (2003). Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3, 489-501.
39. Sano, Y., Harada, J., Tashiro, S., Gotoh-Mandeville, R., Maekawa, T., and Ishii, S. (1999). ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J. Biol. Chem. 274, 8949-8957.
40. Shibata, M., Kanamori, S., Isahara, K., Ohsawa, Y., Konishi, A., Kametaka, S., Watanabe, T., Ebisu, S., Ishido, K., Kominami, E., and Uchiyama, Y. (1998). Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem. Biophys. Res. Commun. 251, 199-203.
41. Sloane, B.F., Yan, S., Podgorski, I., Linebaugh, B.E., Cher, M.L., Mai, J., Cavallo-Medved, D., Sameni, M., Dosescu, J., and Moin, K. (2005). Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Semin. Cancer Biol. 15, 149-157.
42. Tournu, C., Obled, A., Roux, M.P., Deval, C., Ferrara, M., and Béchet, D.M. (1998). Glucose controls cathepsin expression in ras-transformed fibroblasts. Arch. Biochem. Biophys. 360, 15-24.
43. Turk, V., Turk, B., Guncar, G., Turk, D., and Kos, J. (2002). Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv. Enzyme Regul. 42, 285-303.
44. Van den Brule, S., Misson, P., Buhling, F., Lison, D., and Huaux, F. (2005). Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-β. Respir. Res. 6, 84.
45. Voermans, C., van Heese, W.P., de Jong, I., Gerritsen, W.R., and Der Schoot, C.E. (2002). Migratory behavior of leukemic cells from acute myeloid leukemia patients. Leukemia 16, 650-657.
46. von Bubnoff, A. and Cho, K.W. (2001). Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev. Biol. 239, 1-14.
47. Wahl, S.M., Allen, J.B., Weeks, B.S., Wong, H.L., and Klotman, P.E. (1993). Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA 90, 4577-4581.
48. Werle, B., Lötterle, H., Schanzenbaächer, U., Lah, T.T., Kalman, E., Kayser, K., Bülzebruck, H., Schirren, J., Krasovec, M., Kos, J., and Spiess, E. (1999). Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients. Br. J. Cancer 81, 510-519.
49. Werle, B., Kraft, C., Lah, T.T., Kos, J., Schanzenbacher, U., Kayser, K., Ebert, W., and Spiess, E. (2000). Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma. Cancer 89, 2282-2291.
50. Yamada, M., Yoshida, M., and Hashinaka, K. (1993). Identification of transcriptional cis-elements in introns 7 and 9 of the myeloperoxidase gene. J. Biol. Chem. 268, 13479-13485.
51. Yan, S. and Sloane, B.F. (2003). Molecular regulation of human cathepsin B: implication in pathologies. Biol. Chem. 384, 845-854.
52. Yan, S.Q., Sameni, M., and Sloane, B.F. (1998). Cathepsin B and human tumor progression. Biol. Chem. Hoppe-Seyler 379, 113-123.
53. Yan, S., Berquin, I.M., Troen, B.R., and Sloane, B.F. (2000). Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma. DNA Cell Biol. 19, 79-91.
54. Zhang, Y., Feng, X.H., and Derynck, R. (1998). Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394, 909-913.